Venclaxta Tablet 100 mg contains Venetoclax, a targeted oral therapy primarily used for the treatment of hematologic malignancies, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Venetoclax is a BCL-2 inhibitor that promotes apoptosis (programmed cell death) in cancer cells by blocking the BCL-2 protein, which is often overexpressed in malignant cells. This mechanism helps reduce tumor burden and control disease progression effectively.

Venclaxta 100 mg is typically used as part of a carefully titrated regimen, often in combination with other therapies, such as monoclonal antibodies or chemotherapeutic agents, to optimize treatment outcomes while minimizing adverse effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Targeted Therapy: Specifically inhibits BCL-2 protein, triggering cancer cell death.

• Effective in Hematologic Malignancies: Used in CLL and SLL, including high-risk patients with 17p deletion.

• Convenient Oral Administration: Eliminates the need for frequent intravenous treatments.

• Combination Therapy Compatible: Can be used alongside other anti-cancer agents to enhance efficacy.

• Precision Medicine Approach: Tailored to patients with specific genetic markers, improving therapeutic outcomes.

Mechanism of Action

Venetoclax works by:

• BCL-2 Inhibition: Blocks the anti-apoptotic protein BCL-2, restoring programmed cell death in cancer cells.

• Targeted Apoptosis: Eliminates malignant cells resistant to normal cell death mechanisms.

• Enhanced Therapeutic Effect: Supports combination therapy for improved disease control.

Indications

Venclaxta Tablet 100 mg is indicated for:

• Chronic lymphocytic leukemia (CLL) with or without 17p deletion

• Small lymphocytic lymphoma (SLL)

• Use as part of combination therapy under physician supervision

• Patients not suitable for standard chemotherapy

Dosage and Administration

• Administer once daily following a gradual dose escalation schedule to reduce the risk of tumor lysis syndrome (TLS).

• Take with food and a full glass of water to enhance absorption.

• Regular monitoring of blood counts, kidney function, and other laboratory parameters is required.

• Adhere strictly to the prescribed dosing regimen and titration schedule for safety and effectiveness.

Precautions

• Must be used under close medical supervision with frequent laboratory monitoring.

• Ensure adequate hydration to prevent complications from tumor lysis syndrome.

• Avoid grapefruit and medications that interfere with CYP3A enzymes.

• Pregnancy and breastfeeding should be avoided during therapy unless specifically advised.

• Inform the doctor about all other medications and supplements being taken.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Diarrhea or nausea

• Fatigue

• Low white blood cell count (neutropenia)

• Fever

Serious side effects may include:

• Tumor lysis syndrome

• Severe infections

• Low platelet count or anemia

Seek immediate medical attention if severe symptoms like unusual bruising, weakness, sudden nausea, or confusion occur.

Storage

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.